Literature DB >> 8977636

Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines.

M M Webber1, D Bello, S Quader.   

Abstract

Several immortalized and malignant adult human prostatic epithelial cell lines have recently been developed. The three most widely used carcinoma cell lines, DU-145, PC-3, and LNCaP, developed between 1977 and 1980, have greatly contributed to our present understanding of prostate cancer. Before a cell line can be accepted as having prostatic epithelial origin, some basic characteristics must be established. Expression of specific cytokeratins, but absence of desmin and factor VIII, should be first determined to establish epithelial origin. Responsiveness to androgens and expression of androgen receptor and prostate specific antigen should be examined under stringent culture conditions to establish prostatic epithelial origin. Response to growth factors and expression of their receptors facilitates further characterization of cell behavior. Cell lines immortalized by human papillomaviruses (HPVs) are of special interest because HPVs are involved in a variety of anogenital cancers and may also play a role in prostate carcinogenesis. Malignant transformation of HPV-18 immortalized cells with the ras oncogene provides cell systems for investigating the multistep process of carcinogenesis. Each cell line has some unique characteristics, whether it arose directly from a carcinoma or resulted from immortalization with simian virus 40 (SV40) or HPV or was transformed in vitro by oncogenes. Comparisons of these characteristics should facilitate elucidation of the mechanisms involved in initiation, promotion, and progression of prostate cancer. These cell lines will further serve as useful models for investigating tumor progression, invasion, metastasis, new therapeutic strategies, drug resistance, and its reversal and chemoprevention. This review will be published in three parts and will summarize cell markers necessary for characterization, as well as the characteristics and some applications of the immortalized as well as malignant adult human prostatic epithelial cell lines. Part 1 deals with cell markers and the immortalized, nontumorigenic cell lines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977636     DOI: 10.1002/(SICI)1097-0045(199612)29:6<386::AID-PROS7>3.0.CO;2-6

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  19 in total

1.  Androgen-regulated formation and degradation of gap junctions in androgen-responsive human prostate cancer cells.

Authors:  Shalini Mitra; Lakshmanan Annamalai; Souvik Chakraborty; Kristen Johnson; Xiao-Hong Song; Surinder K Batra; Parmender P Mehta
Journal:  Mol Biol Cell       Date:  2006-10-18       Impact factor: 4.138

2.  Modeling transmembrane transport through cell membrane wounds created by acoustic cavitation.

Authors:  Vladimir Zarnitsyn; Christina A Rostad; Mark R Prausnitz
Journal:  Biophys J       Date:  2008-08-01       Impact factor: 4.033

3.  Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor.

Authors:  Shibnath Ghatak; Vincent C Hascall; Roger R Markwald; Suniti Misra
Journal:  J Biol Chem       Date:  2010-03-03       Impact factor: 5.157

4.  Establishment and characterization of a prostate cancer cell line from a prostatectomy specimen for the study of cellular interaction.

Authors:  Ruoxiang Wang; Gina C-Y Chu; Xudong Wang; Jason B Wu; Peizhen Hu; Asha S Multani; Sen Pathak; Haiyen E Zhau; Leland W K Chung
Journal:  Int J Cancer       Date:  2019-05-10       Impact factor: 7.396

5.  VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells.

Authors:  Lymor Ringer; Paul Sirajuddin; Venkata Mahidhar Yenugonda; Anup Ghosh; Kyle Divito; Valerie Trabosh; Yesha Patel; Amanda Brophy; Scott Grindrod; Michael P Lisanti; Dean Rosenthal; Milton L Brown; Maria Laura Avantaggiati; Olga Rodriguez; Chris Albanese
Journal:  Cancer Biol Ther       Date:  2010-08-03       Impact factor: 4.742

Review 6.  Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk.

Authors:  Jason E Michaud; Kevin L Billups; Alan W Partin
Journal:  Ther Adv Urol       Date:  2015-12

7.  Supervised classification of etoposide-treated in vitro adherent cells based on noninvasive imaging morphology.

Authors:  Anna Leida Mölder; Johan Persson; Zahra El-Schich; Silvester Czanner; Anette Gjörloff-Wingren
Journal:  J Med Imaging (Bellingham)       Date:  2017-03-25

8.  Automation of pattern recognition analysis of dynamic contrast-enhanced MRI data to characterize intratumoral vascular heterogeneity.

Authors:  SoHyun Han; Radka Stoyanova; Hansol Lee; Sean D Carlin; Jason A Koutcher; HyungJoon Cho; Ellen Ackerstaff
Journal:  Magn Reson Med       Date:  2017-07-20       Impact factor: 4.668

9.  Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway.

Authors:  Konstantin Golovine; Robert G Uzzo; Peter Makhov; Paul L Crispen; David Kunkle; Vladimir M Kolenko
Journal:  Prostate       Date:  2008-09-15       Impact factor: 4.104

10.  Bicyclic Cyclohexenones as Inhibitors of NF-κB Signaling.

Authors:  Joseph K Hexum; Rodolfo Tello-Aburto; Nicholas B Struntz; Andrew M Harned; Daniel A Harki
Journal:  ACS Med Chem Lett       Date:  2012-05-11       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.